chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3/24 cried in pain off and on throughout the day. Periods of crying became more frequent and intense as day went on. No other symptoms. Urgent care X-ray wasn't normal so referred to hospital. Ultrasound revealed intussusception. Enema, then surgery, followed.
This spontaneous report was received from a health care worker regarding an unspecified number of patients of unknown age and gender. Patient demographics were not provided. Information on the concurrent conditions, medical history and drug allergies of the patients were not reported. On unknown date, unspecified number of patients were administered unspecified number of improperly stored doses of PEDVAXHIB lot # L038501, expiry date 16-AUG-2018 (dose number, dose, frequency, route and anatomical location were not specified) (incorrect product storage). Concomitant medication were not specified. There were no adverse effects reported. There was no product Quality Complaint (PQC) involved. Vaccine was stored at temperature of 20 degree Centigrade for 11 hours, 15 minutes. There was no previous temperature excursion performed. Also GARDASIL 9 appeared in the product list as it was involved in the excursion, however no improperly stored doses of it were administered. This is one of several reports received from same reporter. Additional information has been requested.
On the day of the vaccination, the injection site turned red and raised to a bump about 12 cm x 8cm. It was painful to the touch. On day 7 after the vaccination, the swelling was reduced to 10cm x 6cm, but, it became hot, itchy, painful, and covered in hives. On the morning of day 8, it was solid, lumpy, hard & still itchy and uncomfortable.
crying inconsolable x 4 hrs, on exam at 4PM consolable, smiling.
Within 20 min of getting vaccines she passed out and stopped breathing. Would not wake and needed cpr. Had to take her to the hospital.
administered 1 day past it's expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 1 day past it's expiration date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 1 day past it's expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 1 day past it's expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   The vaccine given was within the allowed/accepted temperature range and right timing. Number of doses/vials was 1 dose. Date the vial was initially stored in the refrigerator 23 Mar 2022. The vial did not undergo any temperature excursions. This was their first booster dose of the Moderna COVID-19 vaccination.  No treatment information was provided.
Information has been received from a physician concerning a 72 year old white retired female with a codeine allergy, hypertension, high cholesterol and osteoporosis who on 17DEC2003, was vaccinated IM in the right deltoid with the second dose of pneumococcal 23v polysaccharide vaccine . No other vaccinations were administered on that same day. Concomitant therapy included alendronate Na, atenolol, Lozol, Lipitor and Valium. There was no illness at the time of vaccination. The physician reported that on 19DEC2003, the pt developed extensive erythema, redness and swelling of her injection site arm with induration. There were no blisters noted. Unspecified medical attention was sought, but no lab/diagnostic tests were performed and no treatment was required. Subsequently, the pt recovered from her events. The physician also reported that another pt developed erythema and swelling of the injection site, fever, hypotension, dizziness and lightheadedness after being vaccinated with pneumococcal 23v polysaccharide vaccine. Additional information is not expected.
Rapid heart rate at 2 am in the morning. HR 150 but I was able to decrease the HR to 120 -130 after several minutes. ( I had a pulse Ox with me at my house.     No chest pain, no SOB,  no tightness in my chest.   I has nausea and vomitting at approx 11:00 pm. Still having shivers that started at 7 pm.
injection site rash; numerous red blemishes on body; body ache; headache; Back ache; Canker sores; Tooth pain; Sore throat; Chills; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 70-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site rash, localized erythema, general body pain, headache, back pain, aphthous stomatitis, toothache, sore throat and chills. On an unknown date, the outcome of the injection site rash, localized erythema, general body pain, headache, back pain, aphthous stomatitis, toothache, sore throat and chills were unknown.   It was unknown if the reporter considered the injection site rash, localized erythema, general body pain, headache, back pain, aphthous stomatitis, toothache, sore throat and chills to be related to Shingrix.  Additional details were provided as follows: The patient experienced severe reaction, rash at injection site, numerous red blemished on body, body aches, headache, backache, canker sore, tooth pain and sore throat chills. It was unknown if the reporter consented to follow up.
Eight days after receiving the second vaccine, I had a heart attack. The reason is unknown as I have none of the markers: high blood pressure, high cholesterol, obesity.
I had a racing heart the next day after getting the vaccine. It felt like I was having heart palpitations. I also had a headache, chest wall pain, and fatigue. Later in the day, closer to 26 hours after getting the vaccine I had loss of appetite and nausea. No vomiting. By the end of the evening, maybe 36 hours later I felt fine. A week later I called my doctor because I was worried about blood clots. On 04/13/2021 I had a CBC with platelets and INR. The INR 1.16 and the CBC was normal. Subsequently, in July I had some of that chest pain and I went to my doctor and they did EKG which showed I had normal sinus rhythm with left bundle branch block, which is an abnormal EKG. They prescribed me Toprol XL.
14 days p/vax fever, body aches, dizzy, severe h/a, chills, loss of appetite, rash;23 days post vax low grade fever, swollen joints & joint pain-ankles, knees, fingers, wrists, elbows, shoulders;
Raised red rash all over body 2 days after receiving vax on 3-9-10.
This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Individual received full dose instead of booster) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Individual received full dose instead of booster). At the time of the report, ACCIDENTAL OVERDOSE (Individual received full dose instead of booster) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications was not provided by the reporter. Treatment information was not provided.
Patient hospitalized for laparotomy cesarean section within 6 weeks of receiving COVID vaccination. Per doctor's notes: She delivered by 1LTCS without complication and was stable post delivery.  She had a 6# 7oz female.  She had an uncomplicated postpartum course, advancing regular diet. Her lochia was normal.  She was  Breastfeeding.  Her vitals remained stable and normal.
Child had a febrile seizures occurring the following day (am) after receiving DTaP, Polio, MMR and varicella at immunization clinic on 7/18/02. Discharge summaries state vomiting, urinary incontience, allergic reaction and lethergy. msv
This spontaneous report as received from a registered nurse via company representative refers to a 9 week old patient of unknown gender. The patient's medical history, current conditions and concomitant medications were not reported. On 12-SEP-2016, the patient was vaccinated with improperly stored dose of PEDVAXHIB, lot # M014926 (strength, dosing details, anatomical location and expiration date were unknown) for prophylaxis. On 01-SEP-2016, temperature excursion of the vaccines occurred in the fridge and was not discovered until 26-SEP-2016. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of the several reports received from the same reporter source. Additional information has been requested. Sender's Comments: US-009507513-1612USA003706.
pt stated the first day she had pain and swelling.  next day she felt like she had flu systems but no fever.  She had swollen lymph nodes on on neck and armpit on left side of her body.  Pt had swelling on both left and right arm and left and right leg and her skin is hurting.  pt saw her PCP which gave her medicine for inflammation.  Pt stated she went to ER on 1/18 since her symptoms had not subsided.  they blood work and sonogram on both legs.  pt  was diagnosed w/ erythema noduson.  Pt had to return to the ER on 1/20.  pt was given steriod meds since blood work came normal.  pt is still on meds and has a FU apt w / rheumatologist in April.
Patient presented to the clinic at approximately 4:25 PM with her spouse and son. She needed a PPD for an application. Employee administered a PPD in the patient's left forearm. She noticed the bleb disappeared immediately so she placed another PPD 2" away from the first site. Patient and spouse returned to the clinic 07 June 2013 in the afternoon to have myself and employee check the site for her PPD pos/neg status. Upon exam, the site was extremely greasy as if the patient had placed an emmollient of some kind on the site. The site (both sites) were red and dry kin. There was no induration. Only redness and what appeared to be a rash. There was a language barrier as the patient could not speak english well. The husband stated that she felt itching of the site the evening it was placed. The spouse said that the pt had placed some kind of cream on the site to help with the discomfort, I put in a TCON for the patient to speak with a nurse as she did not have a provider assigned to her yet. I was informed the nurse contacted them.
After administering DTaP, pt became unresponsive. Several taps to infant's back. Pt started to respond. Mom was advised to take baby to ER for evaluation.
large induration / site of injection; (red circle softball look alike) / site of injection; large induration / back of the knee; (red circle softball look alike) / back of the knee; This case was reported by a pharmacist via call center representative and described the occurrence of injection site induration in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 3SM5G, expiry date 10th April 2022) for prophylaxis.   On 18th September 2020, the patient received the 1st dose of Shingrix. In September 2020, less than a week after receiving Shingrix, the patient experienced injection site induration, injection site erythema, induration and erythema. On an unknown date, the outcome of the injection site induration was not recovered/not resolved and the outcome of the injection site erythema, induration and erythema were unknown.   It was unknown if the reporter considered the injection site induration, injection site erythema, induration and erythema to be related to Shingrix.  Additional details were reported as follows: The patient experienced a large induration (red circle softball looks alike) at the back of the knee and site of injection. The reporter did not consent to follow-up.
Vaccine administered beyond Expiration date. However, per Moderna- all vaccines met viability requirements.  Completing VAERS per town requirements.
My skin hurt, body aches and pains, blinding headache, vomiting No fever or chills this time
Within 5 minutes after vaccination child passed out, jerking motions of extremities were noted. B/P elevated to 158/98. Recovered quickly. Referred to her family physician.
Patient was administered the Moderna COVID-19 vaccine and it was discovered afterward that she is younger than 18yo.
Received the vaccine on the 9th of April. In the middle of the night  started feeling badly. a bit of nausea, headache, body aches and a fever. Stayed in bed most of the day on Saturday and went to bed early on Saturday. Woke up Sunday completely soaked from head to tail. I have never broke a sweat like that before. Felt a bit better, but still not great all day Sunday. Monday I got up and felt better. Had lots of things to do and when I returned home I mowed the lawn. It totally wiped me out, which it never does. I was sweating bullets and extremely thirsty. Today I feel better.
Nasal congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP),  The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: Jan2021, for COVID-19 immunization; Bnt162b2 (Dose 2; second vaccine shot 4 weeks later after dose 1), administration date: 2021, for COVID-19 immunization; Bnt162b2 (Dose: 03 (Booster); first Pfizer booster Sep2021), administration date: Sep2021, for COVID-19 immunization; Bnt162b2 (Dose: 04 (Booster); second booster Mar2022.), administration date: Mar2022, for COVID-19 immunization. The following information was reported: NASAL CONGESTION (non-serious) with onset 2022, outcome "unknown". Additional information: Patient and her husband received the first Pfizer vaccine Jan2021 and second vaccine shot 4 weeks later. They received the first Pfizer booster Sep2021 and the second booster Mar2022. They got the new omicron booster 12Sep2022. They were go happy to remain COVID free until 5 days ago. They looked forward to the new vaccine to protect them from the omicron variant. Their symptoms have been nothing more that nasal congestion, but wanted to pass on the information about the new booster fail.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
After receiving first and second doses of varicella virus vaccine live in 1995, the pts laboratory evaluation revealed failure to seroconvert. The pt was given a third dose of varicella virus vaccine live in January, 1999 and laboratory evaluation on 3/11/99 revealed lack of response. No further information is available.
Mother states noticed right arm reddened, swollen, and hot to the touch from shoulder to elbow. Child complained of slight soreness/discomfort at injection site. Mother gave Motrin, symptoms resolved the next day.
upper respiratory infection; suffered left-sided facial weakness/diagnosed with Bell's Palsy; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On or about 06-MAR-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (exact dose, site and route of administration, lot# and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered left-sided facial weakness and was diagnosed with Bell's Palsy as well as suffered an upper respiratory infection. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms had resulted in physical limitations not present prior to using the vaccine. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the vaccination, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the vaccination, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was reported as not recovered. The relatedness between the events and zoster vaccine live (ZOSTAVAX) was related.  The events of Bell's Palsy and upper respiratory infection were considered to be disabling. Upon internal review, the event of Bell's Palsy was considered to be medically significant.
redness, swelling, warm to the touch, itchiness. Was given ibuprofen 200 mg on 7/18/20 and 7/19/20
presents to ER complaining of dizziness. PMH notable for vertigo. About 5 weeks prior had covid like symptoms but testing was always negative for COVID.  On 12/31 spiked a 103 F. temp but quickly subsided and did not return, no other symptoms noted at that time.  Was found to be COVID positive on 1/4 however currently asymptomatic.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2023) negative, notes: negative tests. Therapeutic measures included Paxlovid from 29Aug2023 to 03Sep2023 were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pain at site of injection and continuous shoulder pain for over one year. Has had X-ray on 11/12/17 for shoulder pain. Went to Doctor 11-16-18 will start Physical Therapy.
Weakness for 4 days from 1st dose.     Loud permanent  Tinnitus on right side from 2nd dose administered on 3/31/2021.
I received my Pfizer COVID-19 booster on 12/10/2021. On 12/28/2021, I began to feel really fatigued and had a sore throat that presented differently than previous sore throats. This sore throat was less scratchy than previous sore throats, but it had more of a burning sensation. I went to a local COVID-19 testing site and underwent a rapid test, which yielded a positive result. I self-isolated for 10 days. For 7 days, I was extremely fatigued, struggled with brain fog, and had a slight cough. I also had very intense headaches that mirrored migraines. The headaches were constant, not sporadic. During the headaches, I had a sensitivity to light. I took ibuprofen, TYLENOL, NYQUIL, and DAYQUIL, but unfortunately, they did not help. I had a telehealth with my doctor, and she told me that my headaches may have been due to my birth control. Because of this, my doctor switched my birth control medication, sent me a pulse oximeter, and refilled my emergency asthma inhaler prescription. During my illness, nothing provided relief for my symptoms. I experienced trouble breathing during this time. I frequently checked my blood oxygen levels, which were always fine, but I still had trouble breathing when I climbed the stairs. I used my inhaler maybe just 3 times during my illness, and it did help with the trouble breathing. For about 4 months after getting the virus, I continued to experience fatigue. At the time of this writing, it has been nearly a year since this happened, and I feel that I am doing fine now. I still have occasional headaches, though I don't know if they are in any way related to COVID-19. I also have occasionally experienced a strange dizziness that I began to have only after getting COVID-19. It's not dizziness in the sense that I experience vertigo, but rather, I can't focus my vision. I sort of feel like my eyes are rolling around in my head. These spells last for only a few hours at a time, and they always occur in the morning upon my waking up. I feel that I have made a recovery for the most part, but not entirely.
Normal side effect at first with an extremely sore arm. A bruise the size of a nickel. Since day 3 aching in the left arm, weakness in that arm, numbness in my left hand. Now 4 weeks later I still have the aching, numbness, bruise and a large dent in my muscle in left arm at location of vaccine.
i kept thinking my lip was swollen last night then when i woke up this morning half of my face is not working. classic bells palsy symptoms. called the dr and we are resarching steroids with the vaccine.
Numbness lips, tongue at night. Provider took off BP meds but asked her to have us do a VAERS report
Tuesday evening 07/23/2013- Headache. Wednesday AM- itching, rash on legs. Thursday rash more pronounced. Mother gave Benadryl dose x1- Rash completely gone within a couple of hours.
(Self described by physician/pt) "got very ill, developed low grade fever, headache, arthralgia, myalagia, fatigue, and flushed" symptoms started to subside on 11/01/2012.
Multiple vaccines occurring at the same time with shingles vaccines and COVID vaccines. Unfortunately COVID vaccine was used instead. Patient was experiencing a small swelling in face in a few minutes and in one hour dizziness. Patient was given Tylenol by niece. At this time patient is okay. Already contacted PCP about incident. Also this is patient's 3rd COVID vaccine since already completed 2 dose series. However, patient unsure which manufacturer received
Patient received 1st booster shot and arm started hurting the next day.  Soreness continues and has not gone away.  It is very painful and she casn not lift her above shoulder at all.  Patient can not sleep on back or side - sleeps sitting up due to pain. Went to doctor in March and physician did an Xray with zero results.  Was told to get an MRI and patient still has to get MRI.  Patient inital series was Moderna and no adverse reaction
Diffuse maculo-papular rash over entire body and face, mostly truncal, but also on extremities and palms and soles.  Also eyelids, lips, labia.  Not in mouth.  Red throat.